Faes Farma S.A [FAE] vs Almirall S.A [ALM] Detailed Stock Comparison
Faes Farma S.A
BME
Loading...
Almirall S.A
BME
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Faes Farma S.A wins in 13 metrics, Almirall S.A wins in 7 metrics, with 0 ties. Faes Farma S.A appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Faes Farma S.A | Almirall S.A | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.41 | 102.60 | Faes Farma S.A |
| Price-to-Book Ratio | 1.80 | 1.51 | Almirall S.A |
| Debt-to-Equity Ratio | 11.48 | 26.47 | Faes Farma S.A |
| PEG Ratio | 14.55 | 22.30 | Faes Farma S.A |
| EV/EBITDA | 10.93 | 12.55 | Faes Farma S.A |
| Profit Margin (TTM) | 19.37% | 2.02% | Faes Farma S.A |
| Operating Margin (TTM) | 18.19% | 3.22% | Faes Farma S.A |
| EBITDA Margin (TTM) | 18.19% | 3.22% | Faes Farma S.A |
| Return on Equity | 14.83% | 1.45% | Faes Farma S.A |
| Return on Assets (TTM) | 6.92% | 1.56% | Faes Farma S.A |
| Free Cash Flow (TTM) | $75.95M | $-664,000 | Faes Farma S.A |
| Dividend Yield | 6.64% | 1.67% | Faes Farma S.A |
| 1-Year Return | 19.89% | 14.70% | Faes Farma S.A |
| Price-to-Sales Ratio (TTM) | 2.42 | 2.09 | Almirall S.A |
| Enterprise Value | $1.28B | $2.24B | Almirall S.A |
| EV/Revenue Ratio | 2.35 | 2.13 | Almirall S.A |
| Gross Profit Margin (TTM) | 69.26% | 91.07% | Almirall S.A |
| Revenue per Share (TTM) | $2 | $5 | Almirall S.A |
| Earnings per Share (Diluted) | $0.34 | $0.10 | Faes Farma S.A |
| Beta (Stock Volatility) | 0.33 | 0.32 | Almirall S.A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Faes Farma S.A vs Almirall S.A Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Faes Farma S.A | 0.00% | -2.09% | -6.43% | -1.17% | 15.30% | 20.23% |
| Almirall S.A | 0.59% | 0.59% | -4.81% | 3.10% | 13.19% | 22.91% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Faes Farma S.A | 19.89% | 7.11% | 21.97% | 67.46% | 66.80% | -47.38% |
| Almirall S.A | 14.70% | 4.89% | 7.74% | -43.75% | 42.86% | -31.42% |
Performance & Financial Health Analysis: Faes Farma S.A vs Almirall S.A
| Metric | FAE | ALM |
|---|---|---|
| Market Information | ||
| Market Cap | €1.31B | €2.20B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 219,874 | 133,831 |
| 90 Day Avg. Volume | 212,247 | 102,185 |
| Last Close | €4.22 | €10.30 |
| 52 Week Range | €3.27 - €4.73 | €8.03 - €11.50 |
| % from 52W High | -10.78% | -10.43% |
| All-Time High | €19.40 (Feb 05, 2007) | €19.09 (Dec 28, 2015) |
| % from All-Time High | -78.25% | -46.05% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.10% |
| Quarterly Earnings Growth | -0.14% | -0.38% |
| Financial Health | ||
| Profit Margin (TTM) | 0.19% | 0.02% |
| Operating Margin (TTM) | 0.18% | 0.03% |
| Return on Equity (TTM) | 0.15% | 0.01% |
| Debt to Equity (MRQ) | 11.48 | 26.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €2.34 | €6.81 |
| Cash per Share (MRQ) | €0.36 | €1.51 |
| Operating Cash Flow (TTM) | €101.14M | €152.00M |
| Levered Free Cash Flow (TTM) | €42.79M | €39.89M |
| Dividends | ||
| Last 12-Month Dividend Yield | 6.64% | 1.67% |
| Last 12-Month Dividend | €0.30 | €0.18 |
Valuation & Enterprise Metrics Analysis: Faes Farma S.A vs Almirall S.A
| Metric | FAE | ALM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.41 | 102.60 |
| Forward P/E | 14.55 | 22.30 |
| PEG Ratio | 14.55 | 22.30 |
| Price to Sales (TTM) | 2.42 | 2.09 |
| Price to Book (MRQ) | 1.80 | 1.51 |
| Market Capitalization | ||
| Market Capitalization | €1.31B | €2.20B |
| Enterprise Value | €1.28B | €2.24B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.35 | 2.13 |
| Enterprise to EBITDA | 10.93 | 12.55 |
| Risk & Other Metrics | ||
| Beta | 0.33 | 0.32 |
| Book Value per Share (MRQ) | €2.34 | €6.81 |
Financial Statements Comparison: Faes Farma S.A vs Almirall S.A
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | FAE | ALM |
|---|---|---|
| Revenue/Sales | €134.64M | €286.10M |
| Cost of Goods Sold | €41.38M | €94.20M |
| Gross Profit | €93.25M | €191.90M |
| Research & Development | N/A | €35.50M |
| Operating Income (EBIT) | €42.59M | €34.20M |
| EBITDA | €42.59M | €72.90M |
| Pre-Tax Income | €32.86M | €35.80M |
| Income Tax | €5.01M | €14.20M |
| Net Income (Profit) | €27.85M | €21.60M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | FAE | ALM |
|---|---|---|
| Cash & Equivalents | €64.22M | €374.40M |
| Total Current Assets | €333.73M | €764.60M |
| Total Current Liabilities | €103.46M | €334.70M |
| Long-Term Debt | N/A | €341.50M |
| Total Shareholders Equity | €726.62M | €1.50B |
| Retained Earnings | €209.04M | N/A |
| Property, Plant & Equipment | €300.94M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | FAE | ALM |
|---|---|---|
| Operating Cash Flow | N/A | €35.70M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | €12.20M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | FAE | ALM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 219,874 | 133,831 |
| Average Daily Volume (90 Day) | 212,247 | 102,185 |
| Shares Outstanding | 311.25M | 213.24M |
| Float Shares | 256.60M | 78.20M |
| % Held by Insiders | 0.13% | 0.65% |
| % Held by Institutions | 0.20% | 0.18% |
Dividend Analysis & Yield Comparison: Faes Farma S.A vs Almirall S.A
| Metric | FAE | ALM |
|---|---|---|
| Last 12-Month Dividend | €0.30 | €0.18 |
| Last 12-Month Dividend Yield | 6.64% | 1.67% |
| 3-Year Avg Annual Dividend | €0.16 | €0.18 |
| 3-Year Avg Dividend Yield | 2.25% | 1.97% |
| 3-Year Total Dividends | €0.49 | €0.54 |
| Ex-Dividend Date | Jul 03, 2025 | May 15, 2025 |